%0 Journal Article
%T Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
%J -
%D 2018
%R https://doi.org/10.1038/s41409-018-0392-1
%X Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with poor long-term survival after cytotoxic chemotherapy. Many novel drugs have revolutionized the treatment algorithms for MM. The impact of targeted therapy, both pre- and post-autologous stem cell transplant (auto-HCT) remains an area of ongoing interest. In this study, we report outcomes post auto-HCT for pPCL and the impact of maintenance therapy posttransplant with novel agents
%U https://www.nature.com/articles/s41409-018-0392-1